Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 179

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Genistein in the Metabolic Syndrome: Results of a Randomized Clinical Trial

Open access
Squadrito, Francesco, Marini, Herbert, Bitto, Alessandra, Altavilla, Domenica, Polito, Francesca, Adamo, Elena Bianca, D'Anna, Rosario, Arcoraci, Vincenzo, Burnett, Bruce P., Minutoli, Letteria, Di Benedetto, Antonino, Di Vieste, Giacoma, Cucinotta, Domenico, de Gregorio, Cesare, Russo, Silvia, Corrado, Francesco, Saitta, Antonino, Irace, Concetta, Corrao, Salvatore, Licata, Giuseppe · 2013 · The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: This study was performed to evaluate the effects of genistein on metabolic and cardiovascular risk factors in Caucasian postmenopausal subjects with metabolic syndrome (MetS). OBJECTIVE: Our objective was to assess the effects of genistein on surrogate endpoints associated with diabetes and cardiovascular disease. DESIGN AND SETTING: This was a randomized, double-blind, placebo-controlled trial at 3 university medical centers in Italy. PATIENTS: Patients included 120 postmenopausal women with MetS according to modified Third Report of the National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) criteria. INTERVENTION: After a 4-week stabilization period, postmenopausal women with MetS were randomly assigned to receive placebo (n = 60) or 54 mg genistein daily (n = 60) for 1 year. MAIN OUTCOME MEASURES: The primary outcome was homeostasis model assessment for insulin resistance (HOMA-IR) at 1 year. Secondary outcomes were fasting glucose, fasting insulin, total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides, visfatin, adiponectin, and homocysteine levels. Data on adverse events were also recorded. RESULTS: At 1 year in genistein recipients, fasting glucose, fasting insulin, and HOMA-IR (mean from 4.5 to 2.7; P < .001) decreased and were unchanged in placebo recipients. Genistein statistically increased HDL-C (mean from 46.4 to 56.8 mg/dL) and adiponectin and decreased total cholesterol, LDL-C (mean from 108.8 to 78.7 mg/dL), triglycerides, visfatin, and homocysteine (mean from 14.3 to 11.7 μmol/L) blood levels. Systolic and diastolic blood pressure was also reduced in genistein recipients. Genistein recipients neither experienced more side adverse effects than placebo nor discontinued the study. CONCLUSION: One year of treatment with genistein improves surrogate endpoints associated with risk for diabetes and cardiovascular disease in postmenopausal women with MetS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2013-1180

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 179

Metadata

Authors
Squadrito, F., Marini, H., Bitto, A., Altavilla, D., Polito, F., Adamo, E. B., D'Anna, R., Arcoraci, V., Burnett, B. P., Minutoli, L., Di Benedetto, A., Di Vieste, G., Cucinotta, D., de Gregorio, C., Russo, S., Corrado, F., Saitta, A., Irace, C., Corrao, S., & Licata, G.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2013-08
Volume
98
Issue
8
Pages
3366-3374
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2038647882
Cited by
179
References
9
FWCI
7.78
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genistein in the Metabolic Syndrome: Results of a Randomized Clinical Trial. https://app.cochat.ai/papers/10.1210/jc.2013-1180
The paper
Squadrito, F., Marini, H., Bitto, A., Altavilla, D., Polito, F., Adamo, E. B., D'Anna, R., Arcoraci, V., Burnett, B. P., Minutoli, L., Di Benedetto, A., Di Vieste, G., Cucinotta, D., de Gregorio, C., Russo, S., Corrado, F., Saitta, A., Irace, C., Corrao, S., & Licata, G. (2013). Genistein in the Metabolic Syndrome: Results of a Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2013-1180

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.